These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 2603477)
1. [Treatment of type I diabetes mellitus with continuous subcutaneous insulin infusion: indications and quality control]. Berger M; Chantelau EA; Spraul M Verh Dtsch Ges Inn Med; 1989; 95():135-40. PubMed ID: 2603477 [No Abstract] [Full Text] [Related]
2. One year continuous run with a totally implantable insulin infusion pump in a human diabetic. Mirouze J; Selam JL; Slingeneyer A; Chaptal PA; Franetzki M; Prestele K; Mion C Trans Am Soc Artif Intern Organs; 1983; 29():709-13. PubMed ID: 6369734 [No Abstract] [Full Text] [Related]
3. [Metabolic control using a subcutaneous insulin infusion pump: effects 2 years after treatment]. Goicolea Opacua I; Martínez Castillo A; Santamaría Pelarda E; Sola Sarabia C; Vázquez García JA Rev Clin Esp; 1988 Mar; 182(4):200-2. PubMed ID: 3045905 [No Abstract] [Full Text] [Related]
4. Six-Year Follow-Up After Insulin Pump Initiation: HbA1c Is Significantly Reduced Without Weight Gain. Andersen HU; Hangaard S; Hommel E; Ridderstråle M J Diabetes Sci Technol; 2018 Mar; 12(2):535-536. PubMed ID: 28927286 [No Abstract] [Full Text] [Related]
5. [The Impact of Prolonged Use of Continuous Subcutaneous Insulin Infusion in the Control of Type-1 Diabetes]. Azevedo S; Saraiva J; Caramelo F; Fadiga L; Barros L; Baptista C; Melo M; Gomes L; Carrilho F Acta Med Port; 2019 Feb; 32(1):17-24. PubMed ID: 30753799 [TBL] [Abstract][Full Text] [Related]
6. The Effects of Subcutaneous Insulin Infusion Versus Multiple Insulin Injections on Glucose Variability in Young Adults with Type 1 Diabetes: The 2-Year Follow-Up of the Observational METRO Study. Maiorino MI; Bellastella G; Casciano O; Cirillo P; Simeon V; Chiodini P; Petrizzo M; Gicchino M; Romano O; Caruso P; Giugliano D; Esposito K Diabetes Technol Ther; 2018 Feb; 20(2):117-126. PubMed ID: 29303370 [TBL] [Abstract][Full Text] [Related]
7. Use of continuous insulin infusion therapy to achieve improved metabolic control. Chiumello G; Meschi F; Beccaria L; Pellini C; di Natale B; Bianchi C Panminerva Med; 1984; 26(3):171-5. PubMed ID: 6522078 [No Abstract] [Full Text] [Related]
8. Assessing glycaemic variability with continuous glucose monitoring system before and after continuous subcutaneous insulin infusion in people with Type 1 diabetes. Chimenti EM; de la Morena LH; Vaquero PM; Sáez-de-Ibarra L; Domínguez MG; Sánchez LF Diabetes Res Clin Pract; 2010 Dec; 90(3):e57-9. PubMed ID: 20855123 [TBL] [Abstract][Full Text] [Related]
9. [Diabetes and the insulin pump: functional results after 5 consecutive years of permanent use]. Mirouze J; Rouault R; Misse P; Millet P; Bordat B; Selam JL; Boudet C Bull Soc Ophtalmol Fr; 1989 Mar; 89(3):437-40. PubMed ID: 2598391 [No Abstract] [Full Text] [Related]
10. Clinical experience with insulin-glycerol solution in an implantable pump. Rupp WM; Rohde TD; Wigness BD; Blackshear PJ; Buchwald H Trans Am Soc Artif Intern Organs; 1983; 29():492-5. PubMed ID: 6369731 [No Abstract] [Full Text] [Related]
11. Comparison of intraperitoneal insulin infusion (using implantable pump) and subcutaneous insulin administration: preliminary results of a crossover study. Jeandidier N; Pinget M; Keipes M; Louy S; Vetter A; Réville P Transplant Proc; 1992 Jun; 24(3):948-9. PubMed ID: 1604678 [No Abstract] [Full Text] [Related]
12. Intensive management of type 1 diabetes in young children. Kaufman FR Lancet; 2005 Feb 26-Mar 4; 365(9461):737-8. PubMed ID: 15733703 [No Abstract] [Full Text] [Related]
13. [Intensive insulin therapy in the diabetic child]. Bougnères PF Union Med Can; 1985 Oct; 114(10):821-8. PubMed ID: 3909569 [No Abstract] [Full Text] [Related]
14. [Insulin pump with glucose sensor in type 1 diabetes. But the artificial pancreas is still far off]. Moberg E Lakartidningen; 2010 Dec 8-14; 107(49):3120-1. PubMed ID: 21284143 [No Abstract] [Full Text] [Related]
15. Maintenance of ambulatory diabetic patients on subcutaneous insulin pump. Raz I; Koffler M; Leitersdorf E; Bar-On H Isr J Med Sci; 1984 Aug; 20(8):731-5. PubMed ID: 6469600 [No Abstract] [Full Text] [Related]
16. Effects of a novel short-term continuous subcutaneous insulin infusion program evaluated by continuous glucose monitoring on young adult type 1 diabetic patients in Taiwan. Lin CH; Huang CH; Tsai JS; Hsieh SH; Sun JH; Huang BY; Huang MJ; Huang YY Endocr J; 2011; 58(10):835-40. PubMed ID: 21828934 [TBL] [Abstract][Full Text] [Related]
17. Maternal and perinatal outcomes in pregnant women with type 1 diabetes treated with continuous subcutaneous insulin infusion and real time continuous glucose monitoring in two specialized centers in Medellin, Colombia. Restrepo-Moreno M; Ramírez-Rincón A; Hincapié-García J; Palacio A; Monsalve-Arango C; Aristizabal-Henao N; Restrepo-Zapata C; Botero-Arango JF J Matern Fetal Neonatal Med; 2018 Mar; 31(6):696-700. PubMed ID: 28264604 [TBL] [Abstract][Full Text] [Related]
18. Continuous Subcutaneous Insulin Infusion Characteristics in Type 1 Diabetes Children and Adolescents in Qatar. Petrovski G; Al Khalaf F; Hussain K; Campbell J; Awwa AE J Diabetes Sci Technol; 2019 Jan; 13(1):144-145. PubMed ID: 30175592 [No Abstract] [Full Text] [Related]
19. Reducing glucose variability with continuous subcutaneous insulin infusion is associated with reversal of axonal dysfunction in type 1 diabetes mellitus. Kamel J; Loh M; Cook M; MacIsaac RJ; Roberts LJ Muscle Nerve; 2020 Jan; 61(1):44-51. PubMed ID: 31613996 [TBL] [Abstract][Full Text] [Related]
20. Clinical value of Flash glucose monitoring in patients with type 1 diabetes treated with continuous subcutaneous insulin infusion. Moreno-Fernandez J; Pazos-Couselo M; González-Rodriguez M; Rozas P; Delgado M; Aguirre M; Garcia-Lopez JM Endocrinol Diabetes Nutr (Engl Ed); 2018 Dec; 65(10):556-563. PubMed ID: 29907546 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]